APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nucleic Acids for Molecular Diagnosis

Compare research editions
View pricing & licenses

Selected research

Industry Research

Nucleic Acids for Molecular Diagnosis Industry Research Report 2026

24 December 2025124 pages

Choose your research edition.

Industry ResearchNucleic Acids for Molecular Diagnosis Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nucleic Acids for Molecular Diagnosis Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Nucleic Acids for Molecular Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nucleic Acids for Molecular Diagnosis Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nucleic Acids for Molecular Diagnosis Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Nucleic Acids for Molecular Diagnosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Nucleic Acids for Molecular Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nucleic Acids for Molecular Diagnosis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nucleic Acids for Molecular Diagnosis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nucleic Acids for Molecular Diagnosis include Agilent Technologies, Inc., Aji Bio-Pharma, Bio-synthesis Inc., Danaher Corporation, Eurofins Scientific SE, Integrated DNA Technologies, Kaneka Eurogentec S.A., L.G.C Biosearch Technologies and Merck KGaA, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Nucleic Acids for Molecular Diagnosis market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nucleic Acids for Molecular Diagnosis.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Nucleic Acids for Molecular Diagnosis Market by Company

Agilent Technologies, Inc.

Aji Bio-Pharma

Bio-synthesis Inc.

Danaher Corporation

Eurofins Scientific SE

Integrated DNA Technologies

Kaneka Eurogentec S.A.

L.G.C Biosearch Technologies

Merck KGaA

metabion

QIAGEN

Thermo Fisher Scientific Inc.

Hongene

Synthgene

Nucleic Acids for Molecular Diagnosis Segment by Type

DNA Series

RNA Series

Nucleic Acids for Molecular Diagnosis Segment by Application

Early Cancer Screening

Genetic Diseases

Blood Screening

Genome Sequencing

Infectious Diseases

Other

Nucleic Acids for Molecular Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acids for Molecular Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acids for Molecular Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acids for Molecular Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Nucleic Acids for Molecular Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Type (2021-2026) Table 7. Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Type (2027-2032) Table 9. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Application (2021-2026) Table 11. Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Application (2027-2032) Table 13. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2021-2026) Table 16. Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2027-2032) Table 18. Nucleic Acids for Molecular Diagnosis Industry Trends Table 19. Nucleic Acids for Molecular Diagnosis Industry Drivers Table 20. Nucleic Acids for Molecular Diagnosis Industry Opportunities and Challenges Table 21. Nucleic Acids for Molecular Diagnosis Market Restraints Table 22. Global Top Nucleic Acids for Molecular Diagnosis Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Players (2021-2026) Table 24. Global Nucleic Acids for Molecular Diagnosis Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Nucleic Acids for Molecular Diagnosis, Headquarters and Area Served Table 26. Global Nucleic Acids for Molecular Diagnosis Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Nucleic Acids for Molecular Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 45. Agilent Technologies, Inc. Company Information Table 46. Agilent Technologies, Inc. Business Overview Table 47. Agilent Technologies, Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 48. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio Table 49. Agilent Technologies, Inc. Recent Developments Table 50. Aji Bio-Pharma Company Information Table 51. Aji Bio-Pharma Business Overview Table 52. Aji Bio-Pharma Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 53. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Portfolio Table 54. Aji Bio-Pharma Recent Developments Table 55. Bio-synthesis Inc. Company Information Table 56. Bio-synthesis Inc. Business Overview Table 57. Bio-synthesis Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 58. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio Table 59. Bio-synthesis Inc. Recent Developments Table 60. Danaher Corporation Company Information Table 61. Danaher Corporation Business Overview Table 62. Danaher Corporation Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 63. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Portfolio Table 64. Danaher Corporation Recent Developments Table 65. Eurofins Scientific SE Company Information Table 66. Eurofins Scientific SE Business Overview Table 67. Eurofins Scientific SE Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 68. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Portfolio Table 69. Eurofins Scientific SE Recent Developments Table 70. Integrated DNA Technologies Company Information Table 71. Integrated DNA Technologies Business Overview Table 72. Integrated DNA Technologies Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 73. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio Table 74. Integrated DNA Technologies Recent Developments Table 75. Kaneka Eurogentec S.A. Company Information Table 76. Kaneka Eurogentec S.A. Business Overview Table 77. Kaneka Eurogentec S.A. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 78. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Portfolio Table 79. Kaneka Eurogentec S.A. Recent Developments Table 80. L.G.C Biosearch Technologies Company Information Table 81. L.G.C Biosearch Technologies Business Overview Table 82. L.G.C Biosearch Technologies Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 83. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio Table 84. L.G.C Biosearch Technologies Recent Developments Table 85. Merck KGaA Company Information Table 86. Merck KGaA Business Overview Table 87. Merck KGaA Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 88. Merck KGaA Nucleic Acids for Molecular Diagnosis Product Portfolio Table 89. Merck KGaA Recent Developments Table 90. metabion Company Information Table 91. metabion Business Overview Table 92. metabion Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 93. metabion Nucleic Acids for Molecular Diagnosis Product Portfolio Table 94. metabion Recent Developments Table 95. QIAGEN Company Information Table 96. QIAGEN Business Overview Table 97. QIAGEN Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 98. QIAGEN Nucleic Acids for Molecular Diagnosis Product Portfolio Table 99. QIAGEN Recent Developments Table 100. Thermo Fisher Scientific Inc. Company Information Table 101. Thermo Fisher Scientific Inc. Business Overview Table 102. Thermo Fisher Scientific Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 103. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio Table 104. Thermo Fisher Scientific Inc. Recent Developments Table 105. Hongene Company Information Table 106. Hongene Business Overview Table 107. Hongene Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 108. Hongene Nucleic Acids for Molecular Diagnosis Product Portfolio Table 109. Hongene Recent Developments Table 110. Synthgene Company Information Table 111. Synthgene Business Overview Table 112. Synthgene Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026) & (US$ Million) Table 113. Synthgene Nucleic Acids for Molecular Diagnosis Product Portfolio Table 114. Synthgene Recent Developments Table 115. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Nucleic Acids for Molecular Diagnosis Product Image Figure 5. Global Nucleic Acids for Molecular Diagnosis Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Nucleic Acids for Molecular Diagnosis Market Share by Type: 2025 VS 2032 Figure 7. DNA Series Product Figure 8. RNA Series Product Figure 9. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Nucleic Acids for Molecular Diagnosis Market Share by Application: 2025 VS 2032 Figure 11. Early Cancer Screening Product Figure 12. Genetic Diseases Product Figure 13. Blood Screening Product Figure 14. Genome Sequencing Product Figure 15. Infectious Diseases Product Figure 16. Other Product Figure 17. Global Nucleic Acids for Molecular Diagnosis Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 18. Global Nucleic Acids for Molecular Diagnosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Nucleic Acids for Molecular Diagnosis Market Share by Region: 2025 VS 2032 Figure 20. Global Nucleic Acids for Molecular Diagnosis Market Share by Players in 2025 Figure 21. Global Nucleic Acids for Molecular Diagnosis Manufacturers Established Date Figure 22. Global Top 5 and 10 Nucleic Acids for Molecular Diagnosis Players Market Share by Revenue in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. North America Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032) Figure 26. United States Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Canada Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Mexico Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032) Figure 29. Europe Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032) Figure 31. Germany Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. France Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. U.K. Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Italy Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Spain Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Russia Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Netherlands Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Nordic Countries Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032) Figure 41. China Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Japan Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. South Korea Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032) Figure 46. Australia Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. China Taiwan Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021-2032) Figure 51. Brazil Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Argentina Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Chile Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Colombia Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Peru Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Agilent Technologies, Inc. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 57. Aji Bio-Pharma Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 58. Bio-synthesis Inc. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 59. Danaher Corporation Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 60. Eurofins Scientific SE Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 61. Integrated DNA Technologies Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 62. Kaneka Eurogentec S.A. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 63. L.G.C Biosearch Technologies Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 64. Merck KGaA Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 65. metabion Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 66. QIAGEN Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 67. Thermo Fisher Scientific Inc. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 68. Hongene Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026) Figure 69. Synthgene Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021-2026)

Scope & coverage.

Types
  • DNA Series
  • RNA Series
Applications
  • Early Cancer Screening
  • Genetic Diseases
  • Blood Screening
  • Genome Sequencing
  • Infectious Diseases
  • Other
Companies covered
  • Agilent Technologies, Inc.
  • Aji Bio-Pharma
  • Bio-synthesis Inc.
  • Danaher Corporation
  • Eurofins Scientific SE
  • Integrated DNA Technologies
  • Kaneka Eurogentec S.A.
  • L.G.C Biosearch Technologies
  • Merck KGaA
  • metabion
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Hongene
  • Synthgene

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Nucleic Acids for Molecular Diagnosis by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 DNA Series
  5. 2.2.3 RNA Series
  6. 2.3 Nucleic Acids for Molecular Diagnosis by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Early Cancer Screening
  9. 2.3.3 Genetic Diseases
  10. 2.3.4 Blood Screening
  11. 2.3.5 Genome Sequencing
  12. 2.3.6 Infectious Diseases
  13. 2.3.7 Other
  14. 2.4 Assumptions and Limitations
3 Nucleic Acids for Molecular Diagnosis Breakdown Data by Type
  1. 3.1 Global Nucleic Acids for Molecular Diagnosis Historic Market Size by Type (2021-2026)
  2. 3.2 Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Type (2027-2032)
4 Nucleic Acids for Molecular Diagnosis Breakdown Data by Application
  1. 4.1 Global Nucleic Acids for Molecular Diagnosis Historic Market Size by Application (2021-2026)
  2. 4.2 Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Nucleic Acids for Molecular Diagnosis Market Perspective (2021-2032)
  2. 5.2 Global Nucleic Acids for Molecular Diagnosis Growth Trends by Region
  3. 5.2.1 Global Nucleic Acids for Molecular Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Nucleic Acids for Molecular Diagnosis Historic Market Size by Region (2021-2026)
  5. 5.2.3 Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Region (2027-2032)
  6. 5.3 Nucleic Acids for Molecular Diagnosis Market Dynamics
  7. 5.3.1 Nucleic Acids for Molecular Diagnosis Industry Trends
  8. 5.3.2 Nucleic Acids for Molecular Diagnosis Market Drivers
  9. 5.3.3 Nucleic Acids for Molecular Diagnosis Market Challenges
  10. 5.3.4 Nucleic Acids for Molecular Diagnosis Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Nucleic Acids for Molecular Diagnosis Players by Revenue
  2. 6.1.1 Global Top Nucleic Acids for Molecular Diagnosis Players by Revenue (2021-2026)
  3. 6.1.2 Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Nucleic Acids for Molecular Diagnosis Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Nucleic Acids for Molecular Diagnosis Head Office and Area Served
  6. 6.4 Global Nucleic Acids for Molecular Diagnosis Players, Product Type & Application
  7. 6.5 Global Nucleic Acids for Molecular Diagnosis Manufacturers Established Date
  8. 6.6 Global Nucleic Acids for Molecular Diagnosis Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
  2. 7.2 North America Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
  4. 7.4 North America Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
  2. 8.2 Europe Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
  4. 8.4 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
  2. 9.2 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
  2. 10.2 South America Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
  4. 10.4 South America Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
  2. 11.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Agilent Technologies, Inc.
  2. 12.1.1 Agilent Technologies, Inc. Company Information
  3. 12.1.2 Agilent Technologies, Inc. Business Overview
  4. 12.1.3 Agilent Technologies, Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  5. 12.1.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
  6. 12.1.5 Agilent Technologies, Inc. Recent Developments
  7. 12.2 Aji Bio-Pharma
  8. 12.2.1 Aji Bio-Pharma Company Information
  9. 12.2.2 Aji Bio-Pharma Business Overview
  10. 12.2.3 Aji Bio-Pharma Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  11. 12.2.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Portfolio
  12. 12.2.5 Aji Bio-Pharma Recent Developments
  13. 12.3 Bio-synthesis Inc.
  14. 12.3.1 Bio-synthesis Inc. Company Information
  15. 12.3.2 Bio-synthesis Inc. Business Overview
  16. 12.3.3 Bio-synthesis Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  17. 12.3.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
  18. 12.3.5 Bio-synthesis Inc. Recent Developments
  19. 12.4 Danaher Corporation
  20. 12.4.1 Danaher Corporation Company Information
  21. 12.4.2 Danaher Corporation Business Overview
  22. 12.4.3 Danaher Corporation Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  23. 12.4.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Portfolio
  24. 12.4.5 Danaher Corporation Recent Developments
  25. 12.5 Eurofins Scientific SE
  26. 12.5.1 Eurofins Scientific SE Company Information
  27. 12.5.2 Eurofins Scientific SE Business Overview
  28. 12.5.3 Eurofins Scientific SE Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  29. 12.5.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Portfolio
  30. 12.5.5 Eurofins Scientific SE Recent Developments
  31. 12.6 Integrated DNA Technologies
  32. 12.6.1 Integrated DNA Technologies Company Information
  33. 12.6.2 Integrated DNA Technologies Business Overview
  34. 12.6.3 Integrated DNA Technologies Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  35. 12.6.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
  36. 12.6.5 Integrated DNA Technologies Recent Developments
  37. 12.7 Kaneka Eurogentec S.A.
  38. 12.7.1 Kaneka Eurogentec S.A. Company Information
  39. 12.7.2 Kaneka Eurogentec S.A. Business Overview
  40. 12.7.3 Kaneka Eurogentec S.A. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  41. 12.7.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Portfolio
  42. 12.7.5 Kaneka Eurogentec S.A. Recent Developments
  43. 12.8 L.G.C Biosearch Technologies
  44. 12.8.1 L.G.C Biosearch Technologies Company Information
  45. 12.8.2 L.G.C Biosearch Technologies Business Overview
  46. 12.8.3 L.G.C Biosearch Technologies Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  47. 12.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Portfolio
  48. 12.8.5 L.G.C Biosearch Technologies Recent Developments
  49. 12.9 Merck KGaA
  50. 12.9.1 Merck KGaA Company Information
  51. 12.9.2 Merck KGaA Business Overview
  52. 12.9.3 Merck KGaA Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  53. 12.9.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Product Portfolio
  54. 12.9.5 Merck KGaA Recent Developments
  55. 12.10 metabion
  56. 12.10.1 metabion Company Information
  57. 12.10.2 metabion Business Overview
  58. 12.10.3 metabion Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  59. 12.10.4 metabion Nucleic Acids for Molecular Diagnosis Product Portfolio
  60. 12.10.5 metabion Recent Developments
  61. 12.11 QIAGEN
  62. 12.11.1 QIAGEN Company Information
  63. 12.11.2 QIAGEN Business Overview
  64. 12.11.3 QIAGEN Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  65. 12.11.4 QIAGEN Nucleic Acids for Molecular Diagnosis Product Portfolio
  66. 12.11.5 QIAGEN Recent Developments
  67. 12.12 Thermo Fisher Scientific Inc.
  68. 12.12.1 Thermo Fisher Scientific Inc. Company Information
  69. 12.12.2 Thermo Fisher Scientific Inc. Business Overview
  70. 12.12.3 Thermo Fisher Scientific Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  71. 12.12.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Portfolio
  72. 12.12.5 Thermo Fisher Scientific Inc. Recent Developments
  73. 12.13 Hongene
  74. 12.13.1 Hongene Company Information
  75. 12.13.2 Hongene Business Overview
  76. 12.13.3 Hongene Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  77. 12.13.4 Hongene Nucleic Acids for Molecular Diagnosis Product Portfolio
  78. 12.13.5 Hongene Recent Developments
  79. 12.14 Synthgene
  80. 12.14.1 Synthgene Company Information
  81. 12.14.2 Synthgene Business Overview
  82. 12.14.3 Synthgene Revenue in Nucleic Acids for Molecular Diagnosis Business (2021-2026)
  83. 12.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Product Portfolio
  84. 12.14.5 Synthgene Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst